Developing approved therapies for ALS has been painfully slow, as evidenced by the failure of more than 95 per cent of ALS ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting terminal illness.

I have ALS, also known as amyotrophic lateral sclerosis or Lou Gehrig’s disease. Named for the famous baseball player, it’s a neuro-degenerative disorder. But I’m not here to discuss the ...

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

After the loss of his mother to ALS, a Kansas City man gave two Chiefs fans who are ALS patients the tour of a lifetime.

Pharmaust Limited ( ($AU:NUZ) ) has issued an announcement. Neurizon Therapeutics Limited announced a delay in the FDA’s review timeline for its ...

By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...

A brain-computer interface has enabled people with paralysis to turn their thoughts directly into words, requiring less ...

The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...

When approached for a quote about Jeffrey D Rothstein, Professor of Neurology and Neuroscience and Director of the Brain Science Institute at Johns Hopkins School of Medicine (Baltimore MD, USA), his ...